Advertisement

Molecular and Cellular Biochemistry

, Volume 416, Issue 1–2, pp 117–129 | Cite as

Evaluation of the effect of n-3 PUFA-rich dietary fish oils on lipid profile and membrane fluidity in alloxan-induced diabetic mice (Mus musculus)

  • Shantal Ganapati Kamat
  • Ramaballav Roy
Article

Abstract

Marine fishes are important to health due to their high content of polyunsaturated fatty acids particularly those of the omega-3 family. These fatty acids play an important role in various physiological processes and as a consequence they may modulate and even prevent some human diseases. The aim of the present study was to investigate and compare the effect of fish oils of different origins (Sardinella longiceps, Rastrelliger kanagurta and Clarias batrachus) on lipid metabolism and membrane fluidity in diabetes. Alloxan was injected in repetitive doses for 1 month (100 mg/kg body weight every 5th day) to induce diabetes in Swiss albino mice. 10 % S. longiceps, R. kanagurta or C. batrachus fish oil was freshly blended with pellet feed which was provided to diabetic mice for 1 month. The serum lipid profile (serum total cholesterol, triglyceride, HDL, VLDL and LDL) along with liver, kidney and heart tissue lipid profile (i.e. triglyceride, total cholesterol, glycolipid and phospholipid) was analysed. Besides, the enzymatic activity of HMG-CoA reductase, HMG-CoA synthase and glucose-6-phosphate-dehydrogenase along with the membrane fluidity of these tissues was evaluated. Altered tissue lipid composition, enzyme activities and membrane fluidity due to diabetes were returned towards normal with the supplementation of 10 % fish oils. Fish oil from S. longiceps brought maximum changes in level of neutral lipid composition in heart, and increased the concentration of phospholipid and decreased the activity of HMG-CoA reductase in comparison with the fish oil from R. kanagurta and C. batrachus.

Keywords

Diabetes Fish oil Lipid Membrane fluidity PUFA Insulin 

Abbreviations

HDL-C

High-density lipoprotein cholesterol

VLDL-C

Very low-density lipoprotein cholesterol

LDL-C

Low-density lipoprotein cholesterol

TG

Triglyceride

MG

Mono-glyceride

DG

Di-glyceride

FFA

Free fatty acid

PL

Phospholipid

TC

Total cholesterol

CE

Cholesteryl esters

HMG-CoA reductase

3-Hydroxy-3-methyl-glutaryl-CoA reductase

HMG-CoA synthase

3-Hydroxy-3-methyl-glutaryl-CoA synthase

G6PD

Glucose-6-phosphate-dehydrogenase

EPA

Eicosapentaenoic acid

DHA

Docosahexaenoic acid

PUFA

Polyunsaturated fatty acid

DM

Diabetes mellitus

Notes

Acknowledgments

Financial support from the University Grant Commission-Special Assistance Programme India (Sanction letter no. F.3-3/2011 (SAPII) is acknowledged. We thank Professor Philip Calder, University of Southampton, for assistance with writing and for comments that greatly improved the manuscript.

Compliance with ethical standards

Conflict of interest

The study was carried out in strict accordance as per the guidelines of CPCSEA (Committee for the Purpose of Control and Supervision on Experiments on Animals, Govt. of India). The authors declare that they have no conflicts of interest concerning this article.

References

  1. 1.
    Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR (1999) Diabetes and cardiovascular disease a statement for healthcare professionals from the American Heart Association. Circulation 100:1134–1146. doi: 10.1161/01.CIR.100.10.1134 CrossRefPubMedGoogle Scholar
  2. 2.
    Gennis RB (1989) Biomembranes: molecular structure and function. Springer, Berlin. ISBN 0387967605CrossRefGoogle Scholar
  3. 3.
    Goldberg IJ (2001) Diabetic dyslipidaemia: causes and consequences. J Clin Endocrinol Metab 86(3):966–971CrossRefGoogle Scholar
  4. 4.
    Feitosa ACR, Feitosa-Filho GS, Freitas FR, Wajchenberg BL, Maranhão RC (2013) Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. Lipids Health Dis 12(15):1–8Google Scholar
  5. 5.
    Balasubramanyam A (2015) Diabetic dyslipidaemia. http://www.medscape.org/viewarticle/418584
  6. 6.
    Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ, Liese AD, D’ Agostino R, Marcovina S, Dabelea D (2009) Lipid and lipoprotein profiles in youth with and without type 1 diabetes. Diabetes Care 32(3):416–420. doi: 10.2337/dc08-1775 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Simpoulous AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70(3):560s–569sGoogle Scholar
  8. 8.
    Zamaria N (2004) Alteration of PUFA status and metabolism in health and disease. Reprod Nutr Dev 44(3):273–282CrossRefPubMedGoogle Scholar
  9. 9.
    Ruxton CSH, Reed SC, Simpson MJA, Millington KJ (2004) The health benefits of omega-3 polyunsaturated fatty acid: a review of the evidence. J Hum Nutr Diet 17:449–459CrossRefPubMedGoogle Scholar
  10. 10.
    Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and Docosahexaenoic acid. Adv Food Nutr Res 65:211–222. doi: 10.1016/B978-0-12-416003-3.00013-5 CrossRefPubMedGoogle Scholar
  11. 11.
    Brownstein J (2014) Fish oil supplements: Sound science or mostly hype. Livescience. http://www.livescience.com/46635-fish-oil-supplements-hype.html. Accessed 02 July 2014
  12. 12.
    Tsuduki T, Honna T, Nakagawa K, Ikeda I, Miyazawa T (2011) Long term intake of fish oil increases oxidative stress and decreases lifespan in senescence- accelerated mice. Nutrition 27:334–337CrossRefPubMedGoogle Scholar
  13. 13.
    Folch J, Less S, Stainley GH (1957) A simple method for isolation and purification of total lipids from animal tissue. J Biol Chem 226:497–509PubMedGoogle Scholar
  14. 14.
    Anstall HB, Trujillo JM (1965) Determination of free fatty acids in plasma by a colorimetric procedure: an appraisal of the method and comparison with other techniques. Clin Chem 11:741–747PubMedGoogle Scholar
  15. 15.
    Kates M (1986) Techniques of lipidology, isolation, analysis and identification of lipids. Elsevier, New YorkGoogle Scholar
  16. 16.
    Carroll NV, Longley RW, Roe JH (1956) The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 220:583–593PubMedGoogle Scholar
  17. 17.
    O’Fallon JV, Busboom JR, Nelson ML, Gaskins CT (2007) A direct method for fatty acid methyl ester synthesis: application to wet meat tissues, oils, and feedstuffs. J Anim Sci 85:1511–1521. doi: 10.2527/jas.2006-491 CrossRefPubMedGoogle Scholar
  18. 18.
    Kleinfeld AM, Dragsten P, Klausner RD, Pjura WJ, Matayoshi ED (1981) The lack of relationship between fluorescence polarization and lateral diffusion in biological membranes. Biochim Biophys Acta 649(2):471–480CrossRefPubMedGoogle Scholar
  19. 19.
    Siedel J (1983) 3-hydroxy-3methylglutaryl-CoA reductase. Mehods of enzymatic analysis, vol 111, 3rd edn. Verlag Chemie GmbH, Weinheim, pp 156–161Google Scholar
  20. 20.
    Miziorko HM (1985) 3-hydroxy-3methylglutaryl-CoA synthase. In: Colowick CO, Kalpana N (eds) Methods in enzymology, vol 110. Academic Press, New York, pp 19–26Google Scholar
  21. 21.
    Anderson W, Nordlie R (1968) Worthington Biochemical Corporation: glucose-6-phosphate dehydrogenase assay manual: glucose dehydrogenase activity of yeast glucose-6-dehydrogenase. I. selective stimulation by bicarbonate, phosphate, and sulfate. Biochemistry 7:1479–1485CrossRefPubMedGoogle Scholar
  22. 22.
    Kamat SG, Roy R (2015) Evaluation of fish oils in amelioration of diabetes-induced tissue damages in mice (Mus musculus). South Asia J Expt Biol 5(1):32–40Google Scholar
  23. 23.
    Kamat SG, Roy R (2015) Evaluation of antioxidant potential of Clarias Batrachus oil in alloxan induced diabetic mice (Mus Musculus). J Diabetes Metab 6:552. doi: 10.4172/2155-6156.1000552 CrossRefGoogle Scholar
  24. 24.
    Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412CrossRefPubMedGoogle Scholar
  25. 25.
    Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRefPubMedGoogle Scholar
  26. 26.
    Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J (2011) The role of oxidative stress and antioxidants in diabetic complications. SQU Med J 12:5–18Google Scholar
  27. 27.
    Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81(8):455–470CrossRefPubMedGoogle Scholar
  28. 28.
    Kromhout D, Bosschieter EB, Coulander CDL (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205–1209CrossRefPubMedGoogle Scholar
  29. 29.
    Kris-Etherton PM, Harris WS, Appel LJ, Burr ML, Gilbert JF (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757. doi: 10.1161/01.CIR0000038493.65177.94 CrossRefPubMedGoogle Scholar
  30. 30.
    Burr ML, Gilbert JF, Hollliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes of fat, fish, and fibre intakes on death from myocardial reinfarction: diet and Reinfarction Trial (DART). Lancet 2:757–761CrossRefPubMedGoogle Scholar
  31. 31.
    Mathew KKAS, Lakshmanan PT (2012) Effect of PUFA from fish oil on lipid metabolism of heart in streptozotocin induced diabetes in male albino mice. J Biomed Sci 1(1):1–7Google Scholar
  32. 32.
    Yates A, Norwig J, Marron JC, Bost J, Bradley JP, Duca M, Wecht DA, Grove R, Iso A, Cobb I, Ross N, Borden M (2009) Evaluation of lipid profiles and use of omega-3 essential fatty acids in professional football players. Sports Health 1(1):21–30CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Sharma N, Garg V (2009) Antidiabetic and antioxidant potential of ethanolic extract from Butea monosperma leaves in alloxan-induced diabetic mice. Indian J Biochem Biophys 46:99–105PubMedGoogle Scholar
  34. 34.
    Qi XY, Chen WJ, Zhang LQ, Xie BJ (2008) Mogrosides extract from Siraitia grosvenorii scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Nutr Res 28(4):278–284. doi: 10.1016/j.nutres.2008.02.008 CrossRefPubMedGoogle Scholar
  35. 35.
    Verges B (2001) Insulin sensitivity and lipids. Diabetes Metab 27(2pt2):223–227PubMedGoogle Scholar
  36. 36.
    Ginsberg HN (1996) Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45(3):S27–S30CrossRefPubMedGoogle Scholar
  37. 37.
    Young NL, Saudek CD, Crawford SA (1982) Total hydroxymethylglutaryl CoA reductase activity in the small intestine and liver of insulin-deficient rats. J Lipid Res 23:266–275PubMedGoogle Scholar
  38. 38.
    Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M (2005) Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54:2328–2335CrossRefPubMedGoogle Scholar
  39. 39.
    Oni GA, Johnson RA, Oguntibeju OO (2005) Detecting patients with glucose-6-phosphate-dehydrogenase deficiency. JIACM 6:42–44Google Scholar
  40. 40.
    Zhang Z, Apse K, Pang J, Stanton RC (2010) High glucose inhibits glucose-6-phosphate-dehydrogenase, leading to increased oxidative stress and β-cell apoptosis. FASEB J 24(5):1497–1505. doi: 10.1096/fj.09-136572 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Xu Y, Osborne B, Stanton RC (2005) Diabetes causes inhibition of glucose-6-phosphate-dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 289:1040–1047CrossRefGoogle Scholar
  42. 42.
    Diaz-Flores M, Ibanez-Harnandez MA, Galvan RE, Gutierrez M, Duran-Reyes G, Median-Navarro R, Pasceo-Lira D, Ortega-Camarillo C, Vilar-Rojas C, Cruz M, Baize-Gutman LA (2006) Glucose-6-phosphate-dehydrogenase activity and NADPH/NADP ratio in liver and pancreas are dependent on the severity of hyperglycaemia in rat. Life Sci 78:2601–2607CrossRefPubMedGoogle Scholar
  43. 43.
    Choy PC, Hatch GM, Man RYK (1997) Phospholipid biosynthesis in health and disease. Adv lipobiol 2:47–78CrossRefGoogle Scholar
  44. 44.
    Novgorodtseva TP, Karaman YK, Zhukova NV, Lobanova EG, Antonyuk MV, Kantur TA (2011) Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids Health Dis 10:82. doi: 10.1186/1476-511X-10-82 CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Waczulíková I, Šikurová L, Čársky J, Štrbová L, Krahulec B (2000) Decreased fluidity of isolated erythrocyte membranes in type 1 and tpe 2 diabetes. The effect of resorcylidene aminoguanidine. Gen Physiol Biophys 19(4):381–392PubMedGoogle Scholar
  46. 46.
    Bryszewska M, Watala C, Torzecka W (1986) Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes. Br J Haematol 62:111–116. doi: 10.1111/j.1365-2141.1986.tb02906.x CrossRefPubMedGoogle Scholar
  47. 47.
    Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, Ziegler O (1995) Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Diabetes Care 18:549–551CrossRefPubMedGoogle Scholar
  48. 48.
    Watala C, Kordacka M, Loba A, Jόzwiak Z, Nowak S (1987) Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents. Acta Diabetol Lat 24:141–148CrossRefPubMedGoogle Scholar
  49. 49.
    Fox TE, Han X, Kelly S, Merrill AH, Marti RE, Aderson RE, Gardner TW, Kester M (2006) Diabetes alters sphingolipid mechanism in retina. Diabetes 55(12):3573–3580CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Abott SK, Else PL, Atkins TA (1818) Hulbert AJ (2012) Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. BBA-Biomembr 5:1309–1317Google Scholar
  51. 51.
    Strolien HH, Kriketos AD, Calvert GD, Baur LA, Jenkins AB (2007) Fatty acids, triglycerides and syndromes of insulin resistance. Prostaglandins and plasma lipid and lipoprotein metabolism in human: a critical review. Diabetes Care 30(4):1012–1024CrossRefGoogle Scholar
  52. 52.
    Soltan MAS (2012) The effects of varieties sources of omega-3 fatty acids on diabetes in rats. FNS 3:1404–1412. doi: 10.4236/fns.2012.310184 CrossRefGoogle Scholar
  53. 53.
    Nestel PJ (1990) Effects of n23 fatty acids on lipid metabolism. Annu Rev Nutr 10:149–167CrossRefPubMedGoogle Scholar
  54. 54.
    Nestel PJ (2000) Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 7(1):228S–231SGoogle Scholar
  55. 55.
    El-Sohemy A, Archer MC (1999) Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids. Lipids 34(10):1037–1043CrossRefPubMedGoogle Scholar
  56. 56.
    Simopoulos AP, Cleland LG (2003) Omega-6/omega-3 essential fatty acid ratio: the scientific evidence. Basel Karger Medical and Scientific Publishers, Basel. doi: 10.1159/000073789 CrossRefGoogle Scholar
  57. 57.
    Matesanz N, ParkG McAllister H, Leahey W, Devine A, McVeigh GE, Gardiner TA, McDonald DM (2010) Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci 51(12):6815–6825. doi: 10.1167/iovs.10-5339 CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Calder PC (2012) Mechanism of action of n-3 fatty acids. J Nutr 142(3):592S–599S. doi: 10.3945/jn.111.155259 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of ZoologyGoa UniversityTaleigao PlateauIndia

Personalised recommendations